News for 2010
The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent agency funded by Canadian federal, provincial, and territorial governments to provide health care decision makers with credible, impartial advice and information about the effectiveness and efficiency of drugs and other health technologies. Unlike regulators who determine which technologies can be used in Canada, CADTH supports decision makers who are exploring what technologies should be used to achieve the best outcomes both on patient health and the health care system.
For details on how to contact CADTH, visit our Contact Us page.
CADTH Liaison Officers Contribute to Alberta’s KT Casebook
December 20, 2010
An article written by CADTH’s western Liaison Officers, entitled “Research to Action: A CADTH Liaison Success,” has been published in Bridging the Gap: Knowledge Translation in ...
CADTH Organizational Announcement
December 17, 2010
CADTH wishes to announce the following changes to its Directors team. Bill Leslie, Director, Impact, Partnerships and Outreach will retire from CADTH on December 31, 2010. He joined CADTH in ...
Article on CADTH’s Rx for Change database published in Implementation Science
December 13, 2010
The latest issue of Implementation Science features an article profiling the Rx for Change database and its role in helping decision-makers access, search for, and use research that will ...
Registration Now Open for the 2011 CADTH Symposium
December 01, 2010
Registration Now Openfor the2011 CADTH SymposiumHyatt Regency Vancouver, Vancouver, British Columbia April 3-5, 2011 This year’s event, themed Evidence to Practice: Maximizing Our ...
A revised version of the report - CADTH Therapeutic Review Clinical and Economic Overview: Biological Response Modifier Agents for Adults with Rheumatoid Arthritis - is now available
November 30, 2010
A revised version of the report - CADTH Therapeutic Review Clinical and Economic Overview: Biological Response Modifier Agents for Adults with Rheumatoid Arthritis - is now available. Details ...
Additional CADTH work on Biologics for Rheumatoid Arthritis Therapeutic Review Reports
November 09, 2010
Based on information received after the release of the final therapeutic review reports on Biologics for Rheumatoid Arthritis, the reports are being modified to improve clarity and provide ...
Patient Group Input to CADTH’s Common Drug Review - Event Webcast and Presentations
November 03, 2010
Presentations Patient Evidence Submissions: Giving Them Power, Harlon Davey CDR Patient input Process: Insights from Janssen-Ortho Inc., Judith Glennie Patient Group Input to ...
Dr. Terrence Sullivan Appointed Chair of CADTH’s Board of Directors
October 06, 2010
Ottawa, Ontario — The Canadian Agency for Drugs and Technologies in Health (CADTH) is pleased to announce that Dr. Terrence Sullivan has been appointed Chair of the CADTH Board of ...
Final Reports from CADTH's Therapeutic Review on Biologics for Rheumatoid Arthritis
July 28, 2010
As part of its therapeutic review pilot project, the Canadian Agency for Drugs and Technologies in Health has conducted a therapeutic review to evaluate the comparative effectiveness, harms, and ...
Call for Nominations for the Drug Policy Advisory Committee
July 21, 2010
What is the Drug Policy Advisory Committee (DPAC)? The Drug Policy Advisory Committee (DPAC) is a new committee, including jurisdictional and non-jurisdictional members, that is being ...
Calls for Board Chair and Director Nominations
June 08, 2010
Health technology is one of the cornerstones of Canada’s health care system. Policy and decision makers across Canada rely on CADTH to provide them with credible, impartial advice ...
New Articles on Self-Monitoring of Blood Glucose
June 07, 2010
The Canadian Agency for Drugs and Technologies in Health (CADTH) is pleased to announce the publication of new articles exploring the utilization, expenditure, and efficacy of self-monitoring of ...
Hip Protectors in Long-Term Care: Policy Guidance and Implementation Tool
May 26, 2010
Hip fractures are a significant health risk for seniors. Hip fractures in long-term care residents may be reduced by preventing and treating osteoporosis, preventing falls, and by using hip ...
CADTH — The Next Chapter: Organizational Changes
May 18, 2010
The following organizational changes and staff appointments have been made to reflect our CADTH – The Next Chapter initiatives. These enhancements underscore the Agency’s commitment ...
CADTH Launches Patient Group Input to CDR
May 13, 2010
Dr. Andreas Laupacis receives Award of Excellence from CADTH
April 21, 2010
Ottawa, Ontario — Dr. Brian O’Rourke, President and CEO of the Canadian Agency for Drugs and Technologies in Health (CADTH), is pleased to announce that Dr. Andreas Laupacis, MD, ...
Board Announcement: President and CEO Appointment
March 22, 2010
The Board of Directors of the Canadian Agency for Drugs and Technologies and Health (CADTH), today confirmed that Dr. Brian O’Rourke will continue his duties with the organization as the ...
CADTH Interim Organizational Assignments
February 23, 2010
Dr. Brian O’Rourke has relinquished his role as Vice-President of the Common Drug Review to focus entirely on his interim duties as President and CEO. With the recent ...